logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
Showing 1 - 2 of 2 Items
Showing 1 - 2 of 2 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Treatment of high-risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes

Luna‐Fineman S, Castellanos M, Metzger ML, Baez LF, Peña Hernandez A,  et al.
2023-12-05 • Pediatric Blood & Cancer
2023-12-05 • Pediatric Blood & Cancer
BACKGROUND/OBJECTIVES
High‐risk Hodgkin lymphoma (HRHL) in children is curable with combined modality therapy. The Association of Pediatric Hematology‐Oncology of Central America (AH...
Journal Article
|
Research

Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa

Geel J, van Zyl A, du Plessis J, Hendricks M, Goga Y,  et al.
2023-10-09 • Pediatric Blood & Cancer
2023-10-09 • Pediatric Blood & Cancer
BACKGROUND
Historic South African 5-year overall survival (OS) rates for Hodgkin lymphoma (HL) from 2000 to 2010 were 46% and 84% for human immunodeficiency virus (HIV)-positive and ...